Research ArticleHuman Studies
The Use of FDG-PET in the Detection and Management of Malignant Lymphoma: Correlation of Uptake with Prognosis
Junichi Okada, Kyosan Yoshikawa, Keiko Imazeki, Satoshi Minoshima, Kimiichi Uno, Jun Itami, Junpei Kuyama, Hirotaka Maruno and Noboru Arimizu
Journal of Nuclear Medicine April 1991, 32 (4) 686-691;
Junichi Okada
Kyosan Yoshikawa
Keiko Imazeki
Satoshi Minoshima
Kimiichi Uno
Jun Itami
Junpei Kuyama
Hirotaka Maruno


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
The Use of FDG-PET in the Detection and Management of Malignant Lymphoma: Correlation of Uptake with Prognosis
Junichi Okada, Kyosan Yoshikawa, Keiko Imazeki, Satoshi Minoshima, Kimiichi Uno, Jun Itami, Junpei Kuyama, Hirotaka Maruno, Noboru Arimizu
Journal of Nuclear Medicine Apr 1991, 32 (4) 686-691;
The Use of FDG-PET in the Detection and Management of Malignant Lymphoma: Correlation of Uptake with Prognosis
Junichi Okada, Kyosan Yoshikawa, Keiko Imazeki, Satoshi Minoshima, Kimiichi Uno, Jun Itami, Junpei Kuyama, Hirotaka Maruno, Noboru Arimizu
Journal of Nuclear Medicine Apr 1991, 32 (4) 686-691;
Jump to section
Related Articles
- No related articles found.
Cited By...
- 18F-FDG PET Is an Independent Outcome Predictor in Primary Central Nervous System Lymphoma
- 18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy
- The Role of PET in Lymphoma
- Prognostic Value of PET Using 18F-FDG in Hodgkin's Disease for Posttreatment Evaluation
- Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
- Lung Cancer Proliferation Correlates with [F-18]Fluorodeoxyglucose Uptake by Positron Emission Tomography
- Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography